Doctors Note Logo

Published on: 10/1/2026

Can you get shingles after the vaccine, and how likely that is

Yes, breakthrough shingles can still occur after vaccination, though it is uncommon and usually milder and shorter-lasting, with a lower risk of complications like postherpetic neuralgia. The two-dose Shingrix series is more than 90% effective at preventing shingles in healthy adults, with protection remaining above 70% for at least four years, while the older Zostavax vaccine offered roughly 50% protection. Risk of a breakthrough case rises with age, weakened immunity, and receiving only one of the two doses, so several factors matter when judging your personal likelihood. See below to understand more about breakthrough symptoms, timing, and when a rash after vaccination is a vaccine reaction rather than true shingles.

Because early antiviral treatment works best within 72 hours of the rash appearing, and because post-vaccine rashes can look like other skin conditions, it helps to sort out what you are dealing with quickly: take a free, instant, online symptom check to better understand your symptoms and decide on your next steps.

Last reviewed for medical accuracy: 10/01/2025

answer background

Explanation

Can you get shingles if you had the vaccine?

Shingles (herpes zoster) is a reactivation of the chickenpox virus (varicella-zoster virus) that lives quietly in nerve cells after an initial infection. The shingles vaccine is designed to reduce your chance of developing this painful rash and to lessen its severity if it does occur. But no vaccine is 100% effective, and breakthrough cases can happen. Here’s what you need to know, based solely on credible sources like the Centers for Disease Control and Prevention (CDC) and peer-reviewed studies.

How the shingles vaccine works

• Two main vaccines are available:

  • Shingrix (recombinant zoster vaccine): Recommended for adults 50 and older.
  • Zostavax (live attenuated vaccine): Older option, less effective than Shingrix.

• Shingrix is given in two doses, 2 to 6 months apart.
• The vaccine boosts your immune response, keeping the virus dormant.

Vaccine effectiveness

Shingles vaccines significantly reduce both the risk and severity of shingles:

• Shingrix efficacy

  • About 97% effective at preventing shingles in adults aged 50–69.
  • About 91% effective in those 70 and older.
  • Protection remains above 85% for at least the first three years after vaccination, then gradually declines.

• Zostavax efficacy

  • About 51% effective at preventing shingles in adults aged 60 and older.
  • Declines to around 40% after five years.

Why you might still get shingles after vaccination

Even a highly effective vaccine can’t guarantee total protection. Reasons for breakthrough shingles include:

• Waning immunity

  • All vaccines lose potency over time. Shingrix protection decreases slowly; Zostavax declines more rapidly.

• Age-related immune decline

  • Older adults have weaker immune systems, making them more vulnerable despite vaccination.

• Underlying health conditions

  • Conditions like HIV, cancer, or autoimmune diseases can impair vaccine response.
  • Medications that suppress immunity (chemotherapy, high-dose steroids) also play a role.

• Rare individual variations

  • Genetics and overall health can affect how well you respond to any vaccine.

How common are breakthrough cases?

• Shingrix

  • Less than 5% of vaccinated individuals develop shingles within the first three years.
  • By year five, estimated risk might rise to around 10% in older adults.

• Zostavax

  • Up to 50% reduction in shingles risk means a higher absolute number of cases compared to Shingrix.

• Comparisons

  • Unvaccinated adults over 60 face a 30% lifetime risk of shingles. Vaccination cuts that risk by more than half in most age groups.

Benefits even if you get shingles

If you do develop shingles after vaccination, your illness is likely to be:

• Milder
• Shorter in duration
• Less likely to cause complications such as postherpetic neuralgia (long-term nerve pain)

Key risk factors for post-vaccine shingles

While vaccination lowers overall risk, certain factors can increase your chance of a breakthrough case:

• Age over 70
• Weakened immune system
• Chronic diseases (diabetes, kidney disease)
• Recent stress or trauma
• High levels of physical or emotional stress

Signs and symptoms to watch for

Shingles usually presents as:

• Pain, burning, tingling, or itching on one side of the body or face
• A red rash that develops into fluid-filled blisters
• Blisters that crust over in 7–10 days and clear up in 2–4 weeks

Early detection can help you start treatment sooner, easing symptoms and reducing complications.

What to do if you suspect shingles

  1. Seek medical care promptly.
  2. Antiviral medications (acyclovir, valacyclovir, famciclovir) work best if started within 72 hours of rash onset.
  3. Pain management may include over-the-counter pain relievers, prescription medications, or topical creams.
  4. Keep the rash clean and dry to prevent bacterial infection.

Consider a free, online symptom check, using the doctor approved Ubie Symptom Checker

If you’re unsure whether you have shingles or another condition, you might find it helpful to complete a free, online symptom check, using the doctor approved Ubie Symptom Checker.

Preventing shingles beyond vaccination

• Healthy lifestyle

  • Balanced diet, regular exercise, adequate sleep and stress management all support your immune system.

• Timely vaccination

  • If you haven’t yet received Shingrix, talk to your healthcare provider about starting the two-dose series.

• Stay informed

  • Follow up on booster recommendations if they become available.

When to talk to your doctor

• Severe pain, widespread rash, fever or headache.
• Rash near the eyes—urgent care needed to avoid vision problems.
• Signs of bacterial infection (increased redness, swelling, pus).
• Any new, unexplained symptoms that concern you.

Remember, while the shingles vaccine greatly reduces your risk, no vaccine offers absolute protection. Breakthrough cases are uncommon, and vaccinated individuals who do develop shingles generally experience much milder illness. Always speak to a doctor about anything potentially serious or life threatening.

Can you get shingles if you had the vaccine? Yes—but vaccination still provides your best defense against shingles and its complications. If you have questions or need personalized advice, speak to your healthcare provider.

(References)

  • * Cogman AR, Chakravarty EF. The case for Zostavax vaccination in systemic lupus erythematosus. Vaccine. 2013 Aug 12;31(36):3640-3. doi: 10.1016/j.vaccine.2013.05.085. Epub 2013 Jun 3. PMID: 23742992; PMCID: PMC3952213.

  • * Yun H, Xie F, Baddley JW, Winthrop K, Saag KG, Curtis JR. Longterm Effectiveness of Herpes Zoster Vaccine among Patients with Autoimmune and Inflammatory Diseases. J Rheumatol. 2017 Jul;44(7):1083-1087. doi: 10.3899/jrheum.160685. Epub 2017 Mar 15. PMID: 28298565; PMCID: PMC5724562.

  • * Schelling J, Rückert-Eheberg IM, Leischker AH. [Protection from a dormant time bomb: The development of effective vaccines against herpes zoster]. MMW Fortschr Med. 2017 Jun;159(10):46-48. doi: 10.1007/s15006-017-9707-1. PMID: 28550546.

  • * Baumrin E, Van Voorhees A, Garg A, Feldman SR, Merola JF. A systematic review of herpes zoster incidence and consensus recommendations on vaccination in adult patients on systemic therapy for psoriasis or psoriatic arthritis: From the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2019 Jul;81(1):102-110. doi: 10.1016/j.jaad.2019.03.017. Epub 2019 Mar 15. PMID: 30885757.

  • * Lu PJ, Hung MC, Srivastav A, Williams WW, Dooling KL. Shingles Vaccination of U.S. Adults Aged 50-59 Years and ≥60 Years Before Recommendations for Use of Recombinant Zoster Vaccine. Am J Prev Med. 2020 Jul;59(1):21-31. doi: 10.1016/j.amepre.2020.01.017. Epub 2020 May 7. PMID: 32389533; PMCID: PMC9196997.

  • * Tafuri S, Bianchi FP, Stefanizzi P. The public health and the question of the "best vaccine". Vaccine. 2022 Jun 21;40(28):3813-3814. doi: 10.1016/j.vaccine.2022.05.044. Epub 2022 May 26. PMID: 35644671; PMCID: PMC9133921.

  • * Chen IL, Chiu HY. Association of herpes zoster with COVID-19 vaccination: A systematic review and meta-analysis. J Am Acad Dermatol. 2023 Aug;89(2):370-371. doi: 10.1016/j.jaad.2023.03.031. Epub 2023 Mar 30. PMID: 37001732; PMCID: PMC10060010.

  • * Kennedy PGE, Grose C. Insights into pathologic mechanisms occurring during serious adverse events following live zoster vaccination. J Virol. 2025 Feb 25;99(2):e0181624. doi: 10.1128/jvi.01816-24. Epub 2025 Jan 17. PMID: 39818965; PMCID: PMC11852805.

  • * Huang Z, Li QQ, Tang Z, Liu S, Zhong D, Sun Q, Wang J, Huang X, Qiu Y, Zhu J, Zhu X, Wang R, He W, Zhao R, Zhang M, Luo H, Luo C, Xu DR. Effectiveness of rapid verbal persuasion in promoting herpes zoster vaccination among older adults in China: study protocol of a two-arm randomised controlled trial. BMJ Open. 2025 Nov 23;15(11):e108051. doi: 10.1136/bmjopen-2025-108051. Epub 2025 Nov 23. PMID: 41285498; PMCID: PMC12645612.

  • * Herpes zoster vaccination may prevent or delay dementia. Drug Ther Bull. 2026 Mar 26;64(4):60. doi: 10.1136/dtb.2026.000005. Epub 2026 Mar 26. PMID: 41887712.

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.